A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy Post author: Post published:October 11, 2023 Post category:uncategorized The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults. You Might Also Like New institute to integrate food-based nutrition interventions into health care October 18, 2023 Efficacy of acupuncture in improving sleep quality for Parkinson’s patients July 1, 2024 More than 20,000 volunteers join effort to accelerate dementia drug development May 15, 2024